Proove Biosciences Announces Executive Additions to Expanding East Coast Corporate Team

Share Article

Proove Biosciences expands its corporate team with a General Counsel and Controller.

With these key additions to our executive team, we continue to put the necessary pieces in place to truly realize the potential of personalized pain medicine- Brian Meshkin

Proove Biosciences, the leading personalized pain medicine laboratory, announced expansions within the Company’s corporate team in its Howard County, Maryland office.

Catherine Meshkin, Esq. has been appointed as Vice President and General Counsel. Catherine will be responsible for legal matters and overseeing Proove Biosciences’ intellectual property and regulatory counsel. Catherine received her law degree from George Mason University School of Law and her undergraduate degree from UCLA. She has served two legal clerkships: one for the Honorable Sharon Prost of the U.S. Court of Appeals, Federal Circuit, and a second for the Honorable Stuart Nash of the Superior Court of the District of Columbia. She is also currently an adjunct professor at the George Mason University School of Law where she teachers Legal Research and Writing.

Marion Frost has been named Controller and Finance Manager. He brings over 20 years of executive-level experience in finance, organizational structuring and business operations. Most recently he was the Chief Operating Officer of VF, Inc, a Baltimore, Maryland based manufacturing company. Marion will be responsible for Proove’s accounting activities and operational development across all company divisions.

Marion Frost states, “I’m excited to join with Brian and the Proove executive team. We are at an exciting time in the history of the Company as we do our best to handle exponential growth. Working with our team across the nation, we are engaged in something profound and powerful yet full of caring. With this attitude permeating everything we do, we cannot possibly fail. I'm proud to be a part of it.”

“We have been growing at an exciting pace this year, and our Maryland team needed key additions in leadership,” stated Brian Meshkin, Founder and CEO of Proove Biosciences. “With these key additions to our executive team, we continue to put the necessary pieces in place to truly realize the potential of personalized pain medicine.”

About Proove Biosciences
Proove Biosciences is the leading Personalized Pain Medicine laboratory that provides proprietary genetic testing services to help physicians improve outcomes for patients and contain costs for insurers. With offices in Southern California and the Baltimore-Washington metropolitan area, the Company is the research leader investigating and publishing data on the genetics of pain medicine with clinical research sites across the United States. Physicians use Proove Biosciences testing to improve pain medicine selection, dosing, and evaluation of medications they prescribe. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit http://www.proovebio.com or call toll free 855-PROOVE-BIO (855-776-6832).

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Nicole McMillan
Proove Biosciences
+1 855-776-6832 716
Email >
@proovebio
since: 02/2012
Follow >
Proove Biosciences, Inc.
since: 01/2012
Like >
Visit website